Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients

The European Respiratory Journal
Muhammad-Hariri MustafaFrançoise Van Bambeke

Abstract

Cystic fibrosis (CF) patients receive chronic treatment with macrolides for their antivirulence and anti-inflammatory properties. We, however, previously showed that Pseudomonas aeruginosa, considered as naturally resistant to macrolides, becomes susceptible when tested in a eukaryotic medium rather than a conventional broth.We therefore looked for specific macrolide resistance determinants in 333 CF isolates from four European CF centres in comparison with 48 isolates from patients suffering from hospital-acquired pneumonia (HAP).Minimum inhibitory concentrations (MICs) of macrolides and ketolides measured in eukaryotic medium (RPMI-1640) were higher towards CF than HAP isolates. Gene sequencing revealed mutations at three positions (2045, 2046 and 2598) in domain V of 23S rRNA of 43% of sequenced CF isolates, but none in HAP isolates. Enzymes degrading extracellular polymeric substances also reduced MICs, highlighting a role of the mucoid, biofilm-forming phenotype in resistance. An association between high MICs and chronic azithromycin administration was evidenced, which was statistically significant for patients infected by the Liverpool Epidemic Strain.Thus, ribosomal mutations are highly prevalent in CF isolates and may s...Continue Reading

References

Nov 18, 2000·Antimicrobial Agents and Chemotherapy·N MasudaT Nishino
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roland Leclercq
Jan 26, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoshinori Nakajima
Jan 26, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph P Lynch III, Fernando J Martinez
Oct 3, 2002·American Journal of Respiratory and Critical Care Medicine·Bonnie W Ramsey
Jan 17, 2004·Clinical Microbiology Reviews·Lisa Saiman, Jane Siegel
Jul 12, 2005·The Journal of Antimicrobial Chemotherapy·Tamiko HisanagaGeorge G Zhanel
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Beatriz Llano-SoteloAlexander S Mankin
Nov 23, 2011·European Journal of Clinical Pharmacology·P ZarogoulidisK Zarogoulidis
Dec 8, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Abdul AshishMartin J Walshaw
Jan 4, 2012·FEMS Microbiology Reviews·Ethan E Mann, Daniel J Wozniak
May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julien M BuyckFrançoise Van Bambeke
May 31, 2012·Antimicrobial Agents and Chemotherapy·Rasmus Lykke MarvigLars Jelsbak
Nov 16, 2012·The Cochrane Database of Systematic Reviews·Kevin W SouthernLatifa Patel
Jan 30, 2013·The Journal of Pharmacology and Experimental Therapeutics·Yoshiki KobayashiKazuhiro Ito
May 6, 2014·Frontiers in Microbiology·Francesco ImperiPaolo Visca
Sep 26, 2014·Advances in Experimental Medicine and Biology·R SiekmeierG Scheuch
Nov 25, 2014·The Journal of Antimicrobial Chemotherapy·Venkata Saran SolletiAbdelwahab Omri
Feb 6, 2016·Expert Review of Anti-infective Therapy·Françoise Van Bambeke, Paul M Tulkens
Mar 26, 2016·Frontiers in Microbiology·Hao TanWeihui Wu
Aug 31, 2016·Antimicrobial Agents and Chemotherapy·Muhammad-Hariri MustafaFrançoise Van Bambeke

❮ Previous
Next ❯

Citations

Oct 27, 2017·Future Microbiology·Carla López-Causapé, Antonio Oliver
Feb 24, 2018·Annals of the American Thoracic Society·Jonathan D CogenMargaret Rosenfeld
May 21, 2017·The European Respiratory Journal·James D Chalmers
Jul 28, 2018·The European Respiratory Journal·Eva PolverinoJames D Chalmers
Mar 16, 2019·American Journal of Respiratory and Critical Care Medicine·Steven L TaylorJodie L Simpson
Nov 7, 2019·International Forum of Allergy & Rhinology·Dong-Jin LimBradford A Woodworth
Jul 30, 2020·International Forum of Allergy & Rhinology·Dong-Jin LimBradford A Woodworth
Sep 6, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Hollian RichardsonJames D Chalmers
Apr 24, 2018·Frontiers in Microbiology·Carla López-CausapéAntonio Oliver
Nov 18, 2018·Nature Reviews. Disease Primers·James D ChalmersPamela J McShane
Oct 23, 2020·Journal of Veterinary Pharmacology and Therapeutics·Pierre-Louis ToutainJohn D Turnidge
Dec 2, 2020·International Journal of Antimicrobial Agents·Kim ThomsenClaus Moser
Apr 3, 2021·Frontiers in Microbiology·Anne-Gaëlle LeroyLise Crémet
Jun 13, 2021·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Kim ThomsenClaus Moser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.